Xact Kapitalforvaltning AB Has $8.34 Million Stake in MetLife, Inc. (MET)
Xact Kapitalforvaltning AB boosted its stake in MetLife, Inc. (NYSE:MET) by 0.1% during the second quarter, Holdings Channel reports. The institutional investor owned 151,706 shares of the financial services provider’s stock after buying an additional 122 shares during the period. Xact Kapitalforvaltning AB’s holdings in MetLife were worth $8,335,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Signature Estate & Investment Advisors LLC purchased a new position in MetLife during the first quarter valued at about $107,000. First Personal Financial Services boosted its position in MetLife by 11.5% in the first quarter. First Personal Financial Services now owns 2,588 shares of the financial services provider’s stock valued at $137,000 after buying an additional 266 shares in the last quarter. Westside Investment Management Inc. boosted its position in MetLife by 583.8% in the first quarter. Westside Investment Management Inc. now owns 2,694 shares of the financial services provider’s stock valued at $140,000 after buying an additional 2,300 shares in the last quarter. Parallel Advisors LLC boosted its position in MetLife by 50.7% in the first quarter. Parallel Advisors LLC now owns 2,748 shares of the financial services provider’s stock valued at $143,000 after buying an additional 924 shares in the last quarter. Finally, First Mercantile Trust Co. purchased a new position in MetLife during the first quarter valued at about $149,000. 74.83% of the stock is owned by hedge funds and other institutional investors.
MetLife, Inc. (NYSE MET) traded down 3.33% during mid-day trading on Thursday, hitting $46.70. 2,865,598 shares of the stock traded hands. The stock has a 50 day moving average price of $48.79 and a 200 day moving average price of $47.33. The firm has a market cap of $49.64 billion, a PE ratio of 549.41 and a beta of 1.46. MetLife, Inc. has a 12-month low of $35.21 and a 12-month high of $51.77.
MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, beating the Zacks’ consensus estimate of $1.28 by $0.02. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The firm had revenue of $17.39 billion for the quarter, compared to the consensus estimate of $17.11 billion. During the same period in the previous year, the firm posted $0.83 earnings per share. The firm’s revenue was up 2.5% on a year-over-year basis. On average, analysts expect that MetLife, Inc. will post $4.87 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 13th. Investors of record on Monday, August 7th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 3.31%. The ex-dividend date of this dividend is Thursday, August 3rd. MetLife’s payout ratio is presently 1,777.98%.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.dailypolitical.com/2017/08/10/xact-kapitalforvaltning-ab-has-8-34-million-stake-in-metlife-inc-met.html.
Several research analysts recently issued reports on the stock. Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a report on Monday. BidaskClub raised shares of MetLife from a “sell” rating to a “hold” rating in a report on Wednesday. Keefe, Bruyette & Woods reissued a “buy” rating and set a $59.00 price target on shares of MetLife in a report on Thursday, August 3rd. Zacks Investment Research cut shares of MetLife from a “hold” rating to a “sell” rating in a report on Wednesday. Finally, TheStreet upgraded shares of MetLife from a “c” rating to a “b-” rating in a research report on Monday, July 24th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $59.10.
MetLife Company Profile
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).
Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.